Hip

7 drugs in development·6 companies·1 clinical trial

Drug Pipeline by Phase

Approved(3)

Drug	Company
apixaban	Mylan II B.V. (MYL)
apixaban	Impax Laboratories, LLC (IPXL)
enoxaparin	Amphastar Pharmaceuticals, Inc. (AMPH)

Phase 3(3)

Phase 2(1)

Drug	Company
VK5211	Viking Therapeutics, Inc. (VKTX)

BioSniper tracks 7 drugs in development for Hip across 6 companies.

There are 1 clinical trial targeting Hip tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.